Adenoscan and Pulse absent - a phase IV clinical study of FDA data

Summary:

Pulse absent is found among people who take Adenoscan, especially for people who are female, 60+ old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Adenoscan and have Pulse absent. It is created by eHealthMe based on reports of 480 people who have side effects when taking Adenoscan from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Oct, 01, 2022

480 people reported to have side effects when taking Adenoscan.
Among them, 8 people (1.67%) have Pulse absent.


What is Adenoscan?

Adenoscan has active ingredients of adenosine. eHealthMe is studying from 482 Adenoscan users for its effectiveness, alternative drugs and more.

What is Pulse absent?

Pulse absent is found to be associated with 1,398 drugs and 835 conditions by eHealthMe.

Number of Adenoscan and Pulse absent reports submitted per year:

Could Adenoscan cause Pulse absent?

Time on Adenoscan when people have Pulse absent *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Pulse absent when taking Adenoscan *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Pulse absent when taking Adenoscan *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common drugs people take besides Adenoscan *:

  1. Cardiolite: 4 people, 50.00%
  2. Ibuprofen: 3 people, 37.50%
  3. Zocor: 2 people, 25.00%
  4. Norvasc: 2 people, 25.00%
  5. Clonidine: 2 people, 25.00%
  6. Humulin R: 2 people, 25.00%
  7. Lotensin: 2 people, 25.00%
  8. Metformin Hydrochloride: 2 people, 25.00%
  9. Pentoxifylline: 2 people, 25.00%
  10. Serevent: 2 people, 25.00%

Common side effects people have besides Pulse absent *:

  1. Ventricular Fibrillation (abnormally irregular heart rhythm): 4 people, 50.00%
  2. Ventricular Tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart): 4 people, 50.00%
  3. Fainting (loss of consciousness and postural tone): 3 people, 37.50%
  4. Cardiac Arrest: 3 people, 37.50%
  5. Muscle Rigidity (muscle stiffness): 2 people, 25.00%
  6. Respiratory Distress (difficulty in breathing): 2 people, 25.00%
  7. Hemiplegia (paralysis of one side of the body): 2 people, 25.00%
  8. Loss Of Consciousness: 2 people, 25.00%
  9. Cough: 2 people, 25.00%
  10. Respiratory Arrest (Excl Neonatal) (cessation of normal respiration due to failure of the lungs to function effectively (excluding neonatal)): 2 people, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Adenoscan and have Pulse absent?

Check whether Pulse absent is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Pulse absent and when was it recovered:

Expand to all the drugs that have ingredients of adenosine:

Alternative drugs to, pros and cons of Adenoscan:

Pulse absent treatments and more:

COVID vaccines that are related to Pulse absent:

Common drugs associated with Pulse absent:

All the drugs that are associated with Pulse absent:

Common conditions associated with Pulse absent:

All the conditions that are associated with Pulse absent:

How the study uses the data?

The study uses data from the FDA. It is based on adenosine (the active ingredients of Adenoscan) and Adenoscan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: